menu
    • menu

    Company profile for AccutarBio

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AccutarBio employs artificial intelligence to revolutionize drug discovery. With capabilities in side chain flexible mode ligand docking, virtual screening, and drug ADME property prediction, Accutar’s platform beats the industry standard in computation-aided drug design. The company’s hybrid based approach, which uses computational drug design followed by wet lab validation, greatly reduces the time and cost necessary for...
    AccutarBio employs artificial intelligence to revolutionize drug discovery. With capabilities in side chain flexible mode ligand docking, virtual screening, and drug ADME property prediction, Accutar’s platform beats the industry standard in computation-aided drug design. The company’s hybrid based approach, which uses computational drug design followed by wet lab validation, greatly reduces the time and cost necessary for traditional drug discovery efforts. Accutar is committed to building strong partnerships, and collaborates across academia and the pharmaceutical industry to solve interdisciplinary problems.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AccutarBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    760 Parkside Ave, Brooklyn, NY 11226
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.accutarbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/accutarbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Accutar Receives FDA Fast Track Designation For AC699 In ER+/HER2- Breast Cancer
    Accutar Receives FDA Fast Track Designation For AC699 In ER+/HER2- Breast Cancer

    14 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240814155176/en

    BUSINESSWIRE
    14 Aug 2024
    Share Share
    Accurar's AC699 Monotherapy Phase 1 Data In ER+/HER2- Breast Cancer
    Accurar's AC699 Monotherapy Phase 1 Data In ER+/HER2- Breast Cancer

    01 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240601126229/en

    BUSINESSWIRE
    01 Jun 2024
    Share Share
    Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
    Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration

    28 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evommune-and-accutar-biotechnology-announce-ai-drug-discovery-collaboration-301996316.html

    PR NEWSWIRE
    28 Nov 2023
    Share Share
    Accutar Announces First Patient Dosed with AC0676 in Phase 1 Study
    Accutar Announces First Patient Dosed with AC0676 in Phase 1 Study

    20 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230620086924/en

    BUSINESSWIRE
    20 Jun 2023
    Share Share
    Accutar Announces First Patient Dosed in China with AC0176 in Phase 1 Study
    Accutar Announces First Patient Dosed in China with AC0176 in Phase 1 Study

    23 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230223005641/en

    BUSINESSWIRE
    23 Feb 2023
    Share Share
    Accutar Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676
    Accutar Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676

    03 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230203005452/en

    BUSINESSWIRE
    03 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search